Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för oncrasin-1. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2020-11-09

Automated synthesis of <sup>18</sup>F radiolabelled indole containing Oncrasin-like molecules; a comparison of iodonium salts and boronic ester chemistry.

McDonald AF, Goh YW, White JM, Scott AM, Ackermann U.

EJNMMI Radiopharm Chem · research-article; journal article · DOI 10.1186/s41181-020-00104-x

Bibliografisk träff 2020-07-29

Identification and targeting of selective vulnerability rendered by tamoxifen resistance.

Singh M, Zhou X, Chen X, Santos GS, Peuget S, Cheng Q, Rihani A, Arnér ESJ, Hartman J, Selivanova G.

Breast Cancer Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s13058-020-01315-5

Bibliografisk träff 2020-02-04

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds.

Peuget S, Zhu J, Sanz G, Singh M, Gaetani M, Chen X, Shi Y, Saei AA, Visnes T, Lindström MS, Rihani A, Moyano-Galceran L, Carlson JW, Hjerpe E, Joneborg U, Lehti K, Hartman J, Helleday T, Zubarev R, Selivanova G.

Cancer Res · research support, non-u.s. gov't; journal article · DOI 10.1158/0008-5472.can-19-2069

Bibliografisk träff 2015-04-08

Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents.

Ma J, Bao G, Wang L, Li W, Xu B, Du B, Lv J, Zhai X, Gong P.

Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2015.04.018

Bibliografisk träff 2011-12-12

Antitumor activity of a novel oncrasin analogue is mediated by JNK activation and STAT3 inhibition.

Guo W, Wu S, Wang L, Wei X, Liu X, Wang J, Lu Z, Hollingshead M, Fang B.

PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0028487

Bibliografisk träff 2011-04-06

Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.

Wu S, Wang L, Guo W, Liu X, Liu J, Wei X, Fang B.

J Med Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm101417n

Bibliografisk träff 2009-02-10

Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).

Guo W, Wu S, Wang L, Wang RY, Wei X, Liu J, Fang B.

Mol Cancer Ther · research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-08-0839

Bibliografisk träff 2008-09-01

Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.

Guo W, Wu S, Liu J, Fang B.

Cancer Res · research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/0008-5472.can-08-1449